NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Anima Biotech

Anima Biotech

Private
Bernardsville, New JerseyHealthcare & Life Scienceshttps://www.animabiotech.com/

Last Round

Strategic

Jan 10, 2023

Total Funding Raised

$226M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Anima Biotech is a biotechnology company that developed the mRNA Lightning platform, which uses AI and visual computing to discover and develop small molecule mRNA drugs.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, ML Platforms

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

AI drug discoverymRNA drug discoverysmall molecule discoveryundruggable targetstechbiodrug discovery platformmRNA modulatorsphenotypic screeningAI image analysismechanism of actionpharmaceutical partnershipsoncology drug discoveryneuroscience drug discoverylive-cell imaging

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Anima Biotech Comparables

Compare Anima Biotech with similar companies based on industry and business-model similarity.

Anima Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Arrakis Therapeutics
89%
Ribometrix
88%
Wayfinder Biosciences
84%

Anima Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicJan 10, 2023
StrategicMar 18, 2021
StrategicJul 23, 2018
SeedMar 26, 2018

Key People

Founding team and executive leadership

Iris Alroy

Co-Founder & Chief Scientific Officer

Founding Team

Yochi Slonim

Co-founder And CEO

Founding Team

Avi Eliassaf

Chief Operating Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 15, 2026

    Monthly visitors increased 145% MoM, reaching 6.1K.

  • Feb 23, 2025

    Monthly visitors increased 41% MoM, reaching 2.4K.

Anima Biotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Anima Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Anima Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersBernardsville, New Jersey
Employee Range56
Year Founded2014
Last FundingJan 10, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.